March 22, 2021

Prestige Scientific Announces Successfully Completed Search for a Director of Analytical Development

News

Milford MA. –Prestige Scientific is excited to announce the successfully completed search for a Director of Analytical Development for our rapidly growing clinical-stage biopharmaceutical client focused on developing human vaccines for the prevention and treatment of life-threatening infectious diseases.

This Director of Analytical Development will report to the Vice President of CMC and will be responsible for defining and deploying the overall technical and scientific approach to vaccine analytical testing and characterization for the company. This individual will immediately dive in as our client prepares for Phase 2 clinical studies. The individual will utilize their proven track record of success with both drug products and drug substances to advance the company’s pipeline via CDMO partnerships. This person will also actively participate in CMC regulatory strategy development and prepare the requisite CMC components of regulatory filings.

Our client’s mission is to develop novel approaches to vaccine design and to create clinically important vaccines which address public health on a global scale.

Congratulations to Butch Hawking for leading this search! Get in touch with Butch, bhawking@prestigescientific.com, or find him on LinkedIn.

About Prestige Scientific:

Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.